Matches in Wikidata for { <http://www.wikidata.org/entity/Q90985591> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- Q90985591 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90985591 description "scientific article published on 29 October 2019" @default.
- Q90985591 description "wetenschappelijk artikel" @default.
- Q90985591 description "наукова стаття, опублікована 29 жовтня 2019" @default.
- Q90985591 description "գիտական հոդված հրատարակված 2019 թվականի հոկտեմբերի 29-ին" @default.
- Q90985591 name "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 name "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 type Item @default.
- Q90985591 label "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 label "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 prefLabel "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 prefLabel "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 P1433 Q90985591-FD4CED60-1077-4DA2-B19F-A821F451112D @default.
- Q90985591 P1476 Q90985591-EE8F02C4-7393-4171-B4DA-AC64E62CCAAF @default.
- Q90985591 P2093 Q90985591-0A8FABFE-4FA9-4D2D-8865-8597A9A856F9 @default.
- Q90985591 P2093 Q90985591-117125BD-9909-462B-9F7C-B0B07AFEAE8A @default.
- Q90985591 P2093 Q90985591-7930DCD1-C1B5-4AED-BC02-BB00318D358B @default.
- Q90985591 P2093 Q90985591-808DB55D-C09C-4BE8-8FE9-4A45F03AFD0B @default.
- Q90985591 P2093 Q90985591-9011BEFB-7745-49C2-949F-46EA32CDA000 @default.
- Q90985591 P2093 Q90985591-A3362237-4FF1-4DC4-BCC8-DC285283BC35 @default.
- Q90985591 P2093 Q90985591-C9F9DB31-9635-45A2-9D27-1AA23BBAA733 @default.
- Q90985591 P2093 Q90985591-CF6640B5-AFA3-4C8B-9088-1F2F084F80AA @default.
- Q90985591 P2093 Q90985591-D68106E5-0282-40A4-AD7C-96F6F934C424 @default.
- Q90985591 P2093 Q90985591-DB0B4820-D95C-4B69-B1D1-351FE0FDB281 @default.
- Q90985591 P2093 Q90985591-ECE4FA30-6A31-4C2C-9E6A-D991216FEE34 @default.
- Q90985591 P304 Q90985591-7AC3E178-7027-46C3-B924-6C4F053269EB @default.
- Q90985591 P31 Q90985591-D7F2F477-E929-4A1B-A582-40ED2B4754D1 @default.
- Q90985591 P356 Q90985591-1A2B037C-E9D0-4EA9-9399-77CA2A371547 @default.
- Q90985591 P433 Q90985591-A7932DA6-9E72-4F76-8B24-D947DAAE8A7D @default.
- Q90985591 P478 Q90985591-2D9274C9-A252-4331-8F51-85B8BA129AE1 @default.
- Q90985591 P50 Q90985591-08240889-A01C-44EB-9F5C-55A97F2DFFC4 @default.
- Q90985591 P50 Q90985591-09BB0EB4-0696-4209-BEBA-F2A2C29CA044 @default.
- Q90985591 P50 Q90985591-0AEE7C4F-DCD6-4F14-B300-929F527359AE @default.
- Q90985591 P50 Q90985591-23BEAD2C-E87B-428E-961F-DF3D204ACAD9 @default.
- Q90985591 P50 Q90985591-36D8CAC1-FB72-4B6B-A8A3-B51B03FB7DD3 @default.
- Q90985591 P50 Q90985591-3E129356-B59B-4581-AADD-DDF487B598C2 @default.
- Q90985591 P50 Q90985591-4D7061AE-9E16-418A-BA86-F96113EB693B @default.
- Q90985591 P50 Q90985591-4F3A19C9-B2F3-4B1F-A1A0-76169787DD68 @default.
- Q90985591 P50 Q90985591-5ABED56C-05D0-40F2-962F-FC0C3B986C61 @default.
- Q90985591 P50 Q90985591-5D59A6EB-6E82-4923-80D2-5809AA3934A7 @default.
- Q90985591 P50 Q90985591-692EAB6A-818D-4C05-813A-743B3F92D08B @default.
- Q90985591 P50 Q90985591-88530775-EDA8-48E4-8F31-05A1E969AC20 @default.
- Q90985591 P50 Q90985591-8AE5049A-69AD-4DC7-8EF7-1728662DB8E0 @default.
- Q90985591 P50 Q90985591-8D637A07-D2EE-44A0-82F6-7DF543AD9F46 @default.
- Q90985591 P50 Q90985591-98C06F24-C548-4E90-9F27-DEC52B84A674 @default.
- Q90985591 P50 Q90985591-9AACD833-7C8A-4370-8C59-3E8591219709 @default.
- Q90985591 P50 Q90985591-AAADAB4E-8534-4DFC-A08B-3A70C150305F @default.
- Q90985591 P50 Q90985591-B4731FF3-88F1-46AB-B85A-F5D99756077B @default.
- Q90985591 P50 Q90985591-DD0D1EE5-9A73-486E-B7C0-D8F82BB2781A @default.
- Q90985591 P50 Q90985591-E0056825-CF0B-4F9E-B6CB-1B78E1AC7997 @default.
- Q90985591 P50 Q90985591-F44554BF-3D39-48F7-81BB-AB1A20562945 @default.
- Q90985591 P577 Q90985591-47C1C754-DDD5-45AE-8B5D-BF54D1569351 @default.
- Q90985591 P698 Q90985591-F8EBD1BA-67B6-4B8B-8062-03BDDB411289 @default.
- Q90985591 P921 Q90985591-F312AAAB-F513-456C-B62C-F52AEA986B28 @default.
- Q90985591 P356 10428194.2019.1678151 @default.
- Q90985591 P698 31661339 @default.
- Q90985591 P1433 Q6534493 @default.
- Q90985591 P1476 "Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG)" @default.
- Q90985591 P2093 "Agnieszka Piekarska" @default.
- Q90985591 P2093 "Agnieszka Pluta" @default.
- Q90985591 P2093 "Anna Krawczynska" @default.
- Q90985591 P2093 "Ewa Bodzenta" @default.
- Q90985591 P2093 "Kamil Brzozowski" @default.
- Q90985591 P2093 "Karol Wojcik" @default.
- Q90985591 P2093 "Konrad Stepka" @default.
- Q90985591 P2093 "Magdalena Czemerska" @default.
- Q90985591 P2093 "Marta Kuydowicz" @default.
- Q90985591 P2093 "Mateusz Nowicki" @default.
- Q90985591 P2093 "Piotr Stelmach" @default.
- Q90985591 P304 "588-603" @default.
- Q90985591 P31 Q13442814 @default.
- Q90985591 P356 "10.1080/10428194.2019.1678151" @default.
- Q90985591 P433 "3" @default.
- Q90985591 P478 "61" @default.
- Q90985591 P50 Q102257445 @default.
- Q90985591 P50 Q114333798 @default.
- Q90985591 P50 Q114333805 @default.
- Q90985591 P50 Q114333834 @default.
- Q90985591 P50 Q11724708 @default.
- Q90985591 P50 Q11749787 @default.
- Q90985591 P50 Q125269837 @default.
- Q90985591 P50 Q125270053 @default.
- Q90985591 P50 Q125311091 @default.
- Q90985591 P50 Q56989878 @default.
- Q90985591 P50 Q58492796 @default.
- Q90985591 P50 Q59677222 @default.
- Q90985591 P50 Q60506473 @default.
- Q90985591 P50 Q61101273 @default.
- Q90985591 P50 Q61157052 @default.
- Q90985591 P50 Q61476048 @default.
- Q90985591 P50 Q83782446 @default.
- Q90985591 P50 Q87746991 @default.
- Q90985591 P50 Q88435517 @default.
- Q90985591 P50 Q90334498 @default.
- Q90985591 P50 Q92489652 @default.
- Q90985591 P577 "2019-10-29T00:00:00Z" @default.
- Q90985591 P698 "31661339" @default.
- Q90985591 P921 Q180983 @default.